SCHEMBL26648083

SCHEMBL26648083

CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(OCCCN5CCN(C(=O)OC(C)(C)C)C(C(C)(C)C)C5)c(S(=O)(=O)C(F)(F)F)c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1

nearest known ligand 0.76

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 19/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL33530304 0.93 BCL2 (0.81) BCL2
SCHEMBL26647919 0.90 BCL2 (0.83) BCL2
SCHEMBL31450702 0.90 BCL2 (0.83) BCL2
SCHEMBL26648065 0.87 BCL2 (0.85) BCL2
SCHEMBL31450830 0.87 BCL2 (0.85) BCL2
SCHEMBL31450938 0.87 BCL2 (0.84) BCL2
SCHEMBL26648821 0.87 BCL2 (0.84) BCL2
SCHEMBL30314055 0.87 BCL2 (1.00) BCL2
SCHEMBL1699870 0.87 BCL2 (1.00) BCL2
SCHEMBL31450967 0.86 BCL2 (0.77) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023220425-A1 BCL-XL/BCL-2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-11-16 — — WO disclosed
Send feedback